tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market

Bright Minds Biosciences (DRUG) Ownership - Who Owns Bright Minds Biosciences?

Compare
222 Followers

Bright Minds Biosciences (DRUG) Ownership Overview

30.98%54.65%0.18%14.19%
30.98% Insiders
54.65% Other Institutional Investors
0.18% ETFs
14.19% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. , 30.98% is owned by Insiders, and 14.19% is owned by Public Companies and Individual Investors.
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 54.83% of the company’s stock is owned by Institutional Investors, 30.98% is owned by Insiders, and 14.19% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 07, 2025
xxxxxxxxxxxxx
C$120960
Mar 07, 2025
xxxxxxxxxxxxx
$180985
Dec 11, 2024
xxxxxxxxxxxxx
C$1411795
Nov 14, 2024
xxxxxxxxxxxxx
$653408

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,059,331Insider15.04%34,693,090
1,004,900Insider14.27%32,910,475
460,829Institution6.54%15,092,150
403,649Institution5.73%13,219,505
57,600Insider0.82%1,886,400
20,609Insider0.29%674,945
19,750Insider0.28%646,813
15,000Insider0.21%491,250
12,481Institution0.18%408,753
5,000Insider0.07%163,750

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
550Institution<0.01%15,857

FAQ

Who Owns Bright Minds Biosciences (DRUG)?
According to the latest TipRanks data, approximately 54.65% of the company's stock is held by institutional investors, 30.98% is held by insiders, and 14.19% is held by retail investors.
    What percentage of Bright Minds Biosciences (DRUG) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 54.65% of Bright Minds Biosciences (DRUG) stock is held by institutional investors.
      What percentage of Bright Minds Biosciences (DRUG) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.19% of Bright Minds Biosciences (DRUG) stock is held by retail investors.
        Who owns the most shares of Bright Minds Biosciences (DRUG)?
        Cormorant Asset Management LP owns the most shares of Bright Minds Biosciences (DRUG).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis